Not available
Quote | Premier Inc. (NASDAQ:PINC)
Last: | $22.10 |
---|---|
Change Percent: | 0.0% |
Open: | $21.83 |
Close: | $22.10 |
High: | $22.12 |
Low: | $21.81 |
Volume: | 1,611,609 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Premier Inc. (NASDAQ:PINC)
2024-03-28 13:49:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 12, 2024 at 2:05 p.m. ET. A link to the live audio...
Message Board Posts | Premier Inc. (NASDAQ:PINC)
Subject | By | Source | When |
---|---|---|---|
$PINC When is this gonna take off? | PostTrifecta | investorshub | 04/29/2023 7:52:16 AM |
are we finally gonna see some action | VisionTrade | investorshub | 04/29/2023 5:23:54 AM |
Looking Bullish! | PostTrifecta | investorshub | 12/05/2019 9:45:22 PM |
I can believe "$TWSI" is trading under a | VisionTrade | investorshub | 01/15/2015 3:19:55 AM |
$TWSI HUGE Purchasing Agreement with Premier, Inc.!! | Stock Rockstar | investorshub | 11/05/2014 5:10:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 12, 2024 at 2:05 p.m. ET. A link to the live audio...
PINC AI ™ , the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals ™ . The full list of recognized hospitals was published in an exclusive online article by Fortune . To create th...
The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...